cloudfront

Report Detail

Pharma & HealthcareGlobal Dry Eye Disease Market Insights, Forecast to 2025

  • RnM2418510
  • |
  • 14 September, 2018
  • |
  • Global
  • |
  • 119 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global Dry Eye Disease Market Insights, Forecast to 2025

Table of Contents

    1 Study Coverage

    • 1.1 Dry Eye Disease Product
    • 1.2 Key Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Dry Eye Disease Market Size Growth Rate by Type
      • 1.4.2 Artificial Tears
      • 1.4.3 Anti-inflammatory (Cyclosporine, Corticosteroid, and Lifitegrast)
      • 1.4.4 Punctal Plugs
      • 1.4.5 Secretagogue
    • 1.5 Market by Application
      • 1.5.1 Global Dry Eye Disease Market Size Growth Rate by Application
      • 1.5.2 Hospital Pharmacies
      • 1.5.3 Independent Pharmacies & Drug Stores
      • 1.5.4 Online pharmacies
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Dry Eye Disease Market Size
      • 2.1.1 Global Dry Eye Disease Revenue 2016-2025
      • 2.1.2 Global Dry Eye Disease Sales 2016-2025
    • 2.2 Dry Eye Disease Growth Rate by Regions
      • 2.2.1 Global Dry Eye Disease Sales by Regions
      • 2.2.2 Global Dry Eye Disease Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Dry Eye Disease Sales by Manufacturers
      • 3.1.1 Dry Eye Disease Sales by Manufacturers
      • 3.1.2 Dry Eye Disease Sales Market Share by Manufacturers
      • 3.1.3 Global Dry Eye Disease Market Concentration Ratio (CR5 and HHI)
    • 3.2 Dry Eye Disease Revenue by Manufacturers
      • 3.2.1 Dry Eye Disease Revenue by Manufacturers (2016-2018)
      • 3.2.2 Dry Eye Disease Revenue Share by Manufacturers (2016-2018)
    • 3.3 Dry Eye Disease Price by Manufacturers
    • 3.4 Dry Eye Disease Manufacturing Base Distribution, Product Types
      • 3.4.1 Dry Eye Disease Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Dry Eye Disease Product Category
      • 3.4.3 Date of International Manufacturers Enter into Dry Eye Disease Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type

    • 4.1 Global Dry Eye Disease Sales by Type
    • 4.2 Global Dry Eye Disease Revenue by Type
    • 4.3 Dry Eye Disease Price by Type

    5 Breakdown Data by Application

    • 5.1 Overview
    • 5.2 Global Dry Eye Disease Breakdown Data by Application

    6 North America

    • 6.1 North America Dry Eye Disease by Countries
      • 6.1.1 North America Dry Eye Disease Sales by Countries
      • 6.1.2 North America Dry Eye Disease Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Dry Eye Disease by Type
    • 6.3 North America Dry Eye Disease by Application
    • 6.4 North America Dry Eye Disease by Company

    7 Europe

    • 7.1 Europe Dry Eye Disease by Countries
      • 7.1.1 Europe Dry Eye Disease Sales by Countries
      • 7.1.2 Europe Dry Eye Disease Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Dry Eye Disease by Type
    • 7.3 Europe Dry Eye Disease by Application
    • 7.4 Europe Dry Eye Disease by Company

    8 Asia Pacific

    • 8.1 Asia Pacific Dry Eye Disease by Countries
      • 8.1.1 Asia Pacific Dry Eye Disease Sales by Countries
      • 8.1.2 Asia Pacific Dry Eye Disease Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Dry Eye Disease by Type
    • 8.3 Asia Pacific Dry Eye Disease by Application
    • 8.4 Asia Pacific Dry Eye Disease by Company

    9 Central & South America

    • 9.1 Central & South America Dry Eye Disease by Countries
      • 9.1.1 Central & South America Dry Eye Disease Sales by Countries
      • 9.1.2 Central & South America Dry Eye Disease Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Dry Eye Disease by Type
    • 9.3 Central & South America Dry Eye Disease by Application
    • 9.4 Central & South America Dry Eye Disease by Company

    10 Middle East and Africa

    • 10.1 Middle East and Africa Dry Eye Disease by Countries
      • 10.1.1 Middle East and Africa Dry Eye Disease Sales by Countries
      • 10.1.2 Middle East and Africa Dry Eye Disease Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Dry Eye Disease by Type
    • 10.3 Middle East and Africa Dry Eye Disease by Application
    • 10.4 Middle East and Africa Dry Eye Disease by Company

    11 Company Profiles

    • 11.1 Santen
      • 11.1.1 Santen Company Details
      • 11.1.2 Company Description
      • 11.1.3 Sales, Revenue and Gross Margin of Dry Eye Disease
      • 11.1.4 Dry Eye Disease Product Description
      • 11.1.5 Recent Development
    • 11.2 Novartis
      • 11.2.1 Novartis Company Details
      • 11.2.2 Company Description
      • 11.2.3 Sales, Revenue and Gross Margin of Dry Eye Disease
      • 11.2.4 Dry Eye Disease Product Description
      • 11.2.5 Recent Development
    • 11.3 llergan
      • 11.3.1 llergan Company Details
      • 11.3.2 Company Description
      • 11.3.3 Sales, Revenue and Gross Margin of Dry Eye Disease
      • 11.3.4 Dry Eye Disease Product Description
      • 11.3.5 Recent Development
    • 11.4 Shire
      • 11.4.1 Shire Company Details
      • 11.4.2 Company Description
      • 11.4.3 Sales, Revenue and Gross Margin of Dry Eye Disease
      • 11.4.4 Dry Eye Disease Product Description
      • 11.4.5 Recent Development
    • 11.5 TRB Chemedica
      • 11.5.1 TRB Chemedica Company Details
      • 11.5.2 Company Description
      • 11.5.3 Sales, Revenue and Gross Margin of Dry Eye Disease
      • 11.5.4 Dry Eye Disease Product Description
      • 11.5.5 Recent Development
    • 11.6 Sun Pharmaceutical
      • 11.6.1 Sun Pharmaceutical Company Details
      • 11.6.2 Company Description
      • 11.6.3 Sales, Revenue and Gross Margin of Dry Eye Disease
      • 11.6.4 Dry Eye Disease Product Description
      • 11.6.5 Recent Development
    • 11.7 Senju
      • 11.7.1 Senju Company Details
      • 11.7.2 Company Description
      • 11.7.3 Sales, Revenue and Gross Margin of Dry Eye Disease
      • 11.7.4 Dry Eye Disease Product Description
      • 11.7.5 Recent Development
    • 11.8 Sentiss Pharma
      • 11.8.1 Sentiss Pharma Company Details
      • 11.8.2 Company Description
      • 11.8.3 Sales, Revenue and Gross Margin of Dry Eye Disease
      • 11.8.4 Dry Eye Disease Product Description
      • 11.8.5 Recent Development
    • 11.9 Johnson & Johnson
      • 11.9.1 Johnson & Johnson Company Details
      • 11.9.2 Company Description
      • 11.9.3 Sales, Revenue and Gross Margin of Dry Eye Disease
      • 11.9.4 Dry Eye Disease Product Description
      • 11.9.5 Recent Development
    • 11.10 Otsuka
      • 11.10.1 Otsuka Company Details
      • 11.10.2 Company Description
      • 11.10.3 Sales, Revenue and Gross Margin of Dry Eye Disease
      • 11.10.4 Dry Eye Disease Product Description
      • 11.10.5 Recent Development
    • 11.11 Mitotech
    • 11.12 FCI

    12 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 12.1 Market Opportunities and Drivers
    • 12.2 Market Challenges
    • 12.3 Market Risks/Restraints
    • 12.4 Key World Economic Indicators

    13 Value Chain and Sales Channels Analysis

    • 13.1 Value Chain Analysis
      • 13.1.1 Typical Suppliers of Key Dry Eye Disease Raw Material
      • 13.1.2 Dry Eye Disease Customers
    • 13.2 Sales Channels Analysis
      • 13.2.1 Sales Channels Analysis
      • 13.2.2 Distributors

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Author Details

      This report studies the global market size of Dry Eye Disease in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Dry Eye Disease in these regions.
      This research report categorizes the global Dry Eye Disease market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

      Dry eye disease is a multifactorial disease which is characterized by insufficiency of tears in eye. Insufficient lubrication in eye lead to burning, sensing, redness and pain in eye.
      In 2017, the global Dry Eye Disease market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Dry Eye Disease market based on company, product type, application and key regions.

      The various contributors involved in the value chain of Dry Eye Disease include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Dry Eye Disease include
      Santen
      Novartis
      llergan
      Shire
      TRB Chemedica
      Sun Pharmaceutical
      Senju
      Sentiss Pharma
      Johnson & Johnson
      Otsuka
      Mitotech
      FCI

      Market Size Split by Type
      Artificial Tears
      Anti-inflammatory (Cyclosporine, Corticosteroid, and Lifitegrast)
      Punctal Plugs
      Secretagogue
      Market Size Split by Application
      Hospital Pharmacies
      Independent Pharmacies & Drug Stores
      Online pharmacies

      Market size split by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Dry Eye Disease market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
      To understand the structure of Dry Eye Disease market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Dry Eye Disease manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Dry Eye Disease with respect to individual growth trends, future prospects, and their contribution to the total market.
      To project the value and volume of Dry Eye Disease submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.

      In this study, the years considered to estimate the market size of Dry Eye Disease are as follows:
      History Year: 2013-2017
      Base Year: 2017
      Estimated Year: 2018
      Forecast Year 2018 to 2025

      This report includes the estimation of market size for value (million US$) and volume (Kg). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Dry Eye Disease market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.




      Summary:
      Get latest Market Research Reports on Dry Eye Disease . Industry analysis & Market Report on Dry Eye Disease is a syndicated market report, published as Global Dry Eye Disease Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Dry Eye Disease market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $7,800.00
      2,618.85
      5,237.70
      3,588.78
      7,177.56
      472,446.00
      944,892.00
      258,622.26
      517,244.52
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report